Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07825649 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Modelization of Early Endometrial-trophoblast Molecular Interaction

Study acronym: MEETMI
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
Despite significant advances in assisted reproductive technology, only 25% of in vitro fertilization (IVF) embryo transfers result in pregnancy, largely due to implantation failure. Preeclampsia complicates 2 to 5% of pregnancies, causes 76,000 maternal deaths worldwide each year, and is one of the leading causes of extreme prematurity (20% of premature births occurring before 32 weeks of gestation). The MEETMI project aims to characterize, in the laboratory, the early endometrium-trophoblast molecular interactions that determine the initial stages of human implantation and placentation. As part of routine care, patients will undergo a diagnostic hysteroscopy during which a endometrial biopsy may be performed. If the patient consents to participate in the study, an additional extended endometrial biopsy will be collected for research purposes.
Trial Details
NCT Number NCT07825649
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Collaborators: Institut Curie, Nantes University Hospital
Conditions
(from sponsor)
Infertility, Eclampsia Preeclampsia
Related terms Infertility, Pre-Eclampsia
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov